On July 30, NPA announced it sent a letter to U.S. Trade Representative Robert E. Lighthizer stating that tariffs on Chinese goods “will cause disproportionate economic harm to U.S. interests and increase costs for small businesses and consumers.”
Innovation in the fiber market is alive and kicking again now that FDA has accepted citizen petitions to classify inulin and other non-digestible carbohydrates as legal dietary fibers.
Tariff Update: More Food, Dietary Supplement Ingredients Caught in Proposed Second Wave of U.S. Tariffs on China
On Tuesday, July 10, the Trump administration released a proposed second list of $200 billion worth of Chinese goods that will face up to a 10% tariff.
In the short time made available for public comments, a number of natural products groups have responded to USDA, citing issues with the proposal.
Nutritional Outlook sought the opinion of few industry stakeholders on whether, in their opinion, the Epidiolex drug approval further threatens the legal status of CBD supplements.
Nutritional Outlook spoke to Scott Steinford, executive director at large of the CoQ10 Association (Salt Lake City, UT), about how trade tensions could negatively affect U.S. and China consumers.
Hemp industry advocates are rejoicing after the Senate passed the Farm Bill yesterday in an 86-11 vote, legalizing the growing of commercial hemp on U.S. soil.
The Hemp Business Journal estimates that retail sales of hemp food and beverage products, personal care products, supplements, car parts, and more, will grow to $1.9 billion by the year 2022.
The new drug, Epidiolex, comprises cannabidiol (CBD), but does not contain tetrahydrocannabinol (THC), the compound in marijuana that causes intoxication.
The bulletin discusses adulteration of turmeric root, turmeric extracts, and curcuminoids with related species, artificial colorants, and synthetic curcuminoids, and details analytical approaches to detect those adulterants.